Normal COMT Genotype
The normal (wild-type) genotype for the COMT gene is Val/Val (also designated as G/G at nucleotide position 472 or 544, encoding valine at amino acid position 108 for the soluble form or 158 for the membrane-bound form).
Understanding COMT Genetic Nomenclature
The COMT gene exhibits a well-characterized functional polymorphism at codon 108/158 (depending on whether referring to the soluble or membrane-bound isoform). The wild-type allele contains:
- Guanine (G) at nucleotide position 472 or 544
- Encodes valine (Val) at amino acid position 108 (soluble) or 158 (membrane-bound)
- Results in high enzyme activity and thermostability 1, 2
Functional Characteristics of Wild-Type COMT
The Val/Val genotype demonstrates:
- Higher enzymatic activity: Red blood cell COMT activity ranges from 0.55-1.03 pmol/min/mg protein in Val/Val homozygotes, compared to 0.21-0.43 pmol/min/mg in Met/Met homozygotes 3
- Greater thermostability: Approximately 2-fold higher thermostability at 48°C compared to the variant form 3
- Higher protein levels: The Val158 variant maintains 70-90% more immunoreactive protein compared to Met158 1, 2
The Common Variant Allele
A common polymorphism exists where:
- G→A transition at nucleotide 472/544
- Results in Val→Met substitution at position 108/158
- Produces a low-activity, thermolabile enzyme 1, 4
The Met variant shows decreased enzyme activity not due to changes in mRNA expression, but rather due to decreased protein stability and enhanced proteolysis 2.
Population Distribution
The two COMT alleles (Val and Met) are approximately equally distributed in most populations:
- Finnish population: Equal distribution of both alleles 3
- Turkish population: Similar frequencies to Caucasians 5
- General pattern: Both alleles maintained at roughly 50% frequency in Caucasian populations 1, 2
This equal distribution suggests balanced selection, where both alleles confer different advantages depending on context.
Clinical Relevance
The wild-type Val/Val genotype results in:
- More efficient catecholamine metabolism in the prefrontal cortex
- Lower synaptic dopamine levels compared to Met carriers 2
- More efficient catechol estrogen inactivation (2-3 fold higher than Met/Met) 4
Understanding which genotype is "normal" is important for pharmacogenomic applications, particularly in levodopa therapy for Parkinson's disease and in understanding individual variation in dopamine-dependent cognitive functions 6, 7, 8.